Generics - Sanofi


Current filters:


Popular Filters

Breckenridge Pharma files ANDA for generic of Sanofi’s Jevtana


Privately-held US generic drugmaker Breckenridge Pharmaceutical has filed an Abbreviated New Drug Application…

Breckenridge PharmaceuticalsGenericsJevtanaOncologyPatentsRegulationSanofiUSA

Mylan starts Ph III trials for generics of Advair Diskus and insulin analog to Lantus


US generic drugs major Mylan says it is initiating Phase III clinical trials for its generic version…

Advair DiskusDiabetesGenericsGlaxoSmithKlineLantusMylanResearchRespiratory and PulmonarySanofi

Sanofi unit launches authorized generic of Eloxatin

Sanofi unit launches authorized generic of Eloxatin


The US subsidiary of French pharma major Sanofi says it has launched an authorized generic version of…

Advanced colorectal cancerEloxatinGenericsMarkets & MarketingOncologyOxaliplatinSanofiUSA

India’s Lupin launches insulin glargine analogue Basugine


Indian generic drugmaker Lupin has entered into a strategic distribution agreement with LG Life Sciences…

BasugineBiosimilarsDiabetesGenericsIndiaLantusLG Life SciencesLupinMarkets & MarketingPeptide hormonesRecombinant proteinsSanofi

Dubai Investments sells 66% stake in Globalpharma to Sanofi


Dubai Investments PJSC, the leading investment company listed on the Dubai financial market [DFM], has…

GenericsGlobalpharmaMergers & AcquisitionsRest of the WorldSanofi

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016


Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar


The Superior Court of Justice in Brazil recently annulled marketing approval for a sub-standard biosimilar…

BiosimilarsDoxelibGenericsLegalLibra LaboratoryOncologyRegulationSanofiSouth AmericaTaxotere

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer


The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

Sanofi yet another to be hit by generic competition


Continuing the trend reported by other drug majors reporting third-quarter 2012 financial results so…


Watson gets FDA approval for generic Sanctura XR and Avapro


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has received approval from the US Food and Drug…

AllerganAvaproCardio-vascularGenericsGenito-urinaryNorth AmericaRegulationSanctura XRSanofiWatson Pharmaceuticals

Pharma vs the world: Big Pharma caught between investors and public


Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Teva launches generic Aprovel in UK


The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic…

AprovelBristol-Myers SquibbCardio-vascularEuropeGenericsMarkets & MarketingSanofiTeva Pharmaceutical Industries

Bristol-Myers anticipates significant decline in US clopidogrel sales as patent lapses


GenericsWeb, a patent analysis and search company, recently published an article based on its proprietary…

Bristol-Myers SquibbCardio-vascularClopidogrelGenericsPatentsPharmaceuticalPlavixSanofi

Back to top